Provided by Tiger Trade Technology Pte. Ltd.

VENUS MEDTECH-B

1.225
+0.0554.70%
Volume:1.82M
Turnover:2.27M
Market Cap:540.24M
PE:-1.13
High:1.350
Open:1.170
Low:1.170
Close:1.170
52wk High:4.030
52wk Low:0.940
Shares:441.01M
HK Float Shares:441.01M
Volume Ratio:1.56
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.088
ROE:-25.85%
ROA:-8.86%
PB:0.30
PE(LYR):-1.13
PS:1.81

Loading ...

Venus Medtech Calls 30 September 2026 EGM to Seek Approval for New Share and Convertible Bond Issue; Announces 25–30 September Book Closure

Bulletin Express
·
Sep 11

Venus Medtech Schedules Extraordinary General Meeting

Reuters
·
Sep 11

Hong Kong Stocks Fall as Oil Extends Rally; Venus Medtech Gains

MT Newswires Live
·
Sep 11

Venus Medtech Plans 500 Million Yuan Share, Convertible Bond Subscription

MT Newswires Live
·
Sep 11

Venus Medtech to Raise Up to RMB500.00 Million via Share Placement and Convertible Bonds

Bulletin Express
·
Sep 10

Venus Medtech Hangzhou - to Issue 184.5 Mln Shares and Hk$379.7 Mln Convertible Bonds

THOMSON REUTERS
·
Sep 10

Venus Medtech Hangzhou - Subscription Price Per Share is Hk$1.078

THOMSON REUTERS
·
Sep 10

Venus MedTech Agrees Private Placement of 184,536,703 Shares at HKD 1.08 Each

Reuters
·
Sep 10

Venus Medtech Keeps Share Structure Unchanged in August 2026, Confirms Adequate Public Float

Bulletin Express
·
Sep 03

We Might See A Profit From Venus Medtech (Hangzhou) Inc. (HKG:2500) Soon

Simply Wall St.
·
Sep 03

Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million

Reuters
·
Aug 31

Venus Medtech H1 2026: Revenue Falls 27.6%, Net Loss Widens to RMB 191 Million

Bulletin Express
·
Aug 31

Venus MedTech FY26 H1 Net Loss Widens 41.9% to RMB 191.31 Million; Revenue Falls 27.6% to RMB 135.5 Million

Reuters
·
Aug 31

Venus Medtech Hangzhou - Six-Month Revenue Rmb135.5 Mln

THOMSON REUTERS
·
Aug 31

Venus Medtech Sets 31 Aug 2026 Board Meeting to Review 1H26 Interim Results

Bulletin Express
·
Aug 19

Venus Medtech-B: July 2026 Filing Shows Static Share Base and Full Public-Float Compliance

Bulletin Express
·
Aug 05

Venus Medtech Flags Availability of Press Release on Venus-powerx TAVR Trial Update

Reuters
·
Jul 23

Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-powerx, the World's First Fully Recoverable Self-expanding Dry-valve Tavr System

THOMSON REUTERS
·
Jul 23

Venus Medtech Maintains Stable Share Base in June 2026; Confirms Public-Float Compliance

Bulletin Express
·
Jul 06

Venus Medtech-B Announces Lapse of Convertible Bond Subscription Agreement

Stock News
·
Jul 06